Arnhild Bakken retweetledi

Proud and greatful to share the primary results with this fantastic team (@dan_atar E Prescott AM Kristensen, JE Otterstad) and the Norwegian and Danish cardiac community! Thanks to prof John Cleland for a great discussion.
@NEJM @escardio #ESC2025 @VestreViken @atferdsmedisin

NEJM@NEJM
Presented at #ESCCongress: Among patients with myocardial infarction and a left ventricular ejection fraction of at least 40%, beta-blockers led to a lower risk of death or major cardiovascular events than no beta-blocker therapy. Full BETAMI–DANBLOCK trial results: nej.md/4oT6aSg @escardio
English





























